z-logo
open-access-imgOpen Access
Biologically Equivalent Substitutive Technology: What is Needed to Manufacture Pluripotent Stem Cells for Next-Generation Platforms for Discovery and Therapy
Author(s) -
Paul A. De Sousa
Publication year - 2013
Publication title -
regenerative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 63
eISSN - 1746-076X
pISSN - 1746-0751
DOI - 10.2217/rme.13.50
Subject(s) - regenerative medicine , induced pluripotent stem cell , stem cell , drug discovery , embryonic stem cell , biology , microbiology and biotechnology , bioinformatics , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom